Caretti Giuseppina

The Lysine Methylase {SMYD}3 Modulates Mesendodermal Commitment during Development / R. Fittipaldi, P. Floris, V. Proserpio, F. Cotelli, M.D. Beltrame, G. Caretti. - In: CELLS. - ISSN 2073-4409. - 10:5(2021 May 18). [10.3390/cells10051233]

BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy / M. Segatto, R. Szokoll, R. Fittipaldi, C. Bottino, L. Nevi, K. Mamchaoui, P. Filippakopoulos, G. Caretti. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 11:1(2020 Nov 30). [10.1038/s41467-020-19839-x]

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality / P. Sanese, C. Fasano, G. Buscemi, C. Bottino, S. Corbetta, E. Fabini, V. Silvestri, V. Valentini, V. Disciglio, G. Forte, M. Lepore Signorile, K. De Marco, S. Bertora, V. Grossi, U. Guven, N. Porta, V. Di Maio, E. Manoni, 5. Gianluigi Giannelli, M. Bartolini, A. Del Rio, G. Caretti, L. Ottini, C. Simone. - In: ISCIENCE. - ISSN 2589-0042. - 23:10(2020 Oct 23).

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis / C. Tonini, M. Colardo, B. Colella, S. Di Bartolomeo, F. Berardinelli, G. Caretti, V. Pallottini, M. Segatto. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 21:4(2020 Feb 02).

SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways / G. Caretti, C. Bottino, A. Peserico, C. Simone. - In: CANCERS. - ISSN 2072-6694. - 12:1(2020 Jan 01).